Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07756372
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions for Patients With a Progressive Collapsing Foot DeformityCanadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07756372Not Yet Recruiting
Not Applicable
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions fo...Canadian Institutes of He...
NCT07756034
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in CancerBlood Cancer UnitedRecruiting
NCT07756034Recruiting
—
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platfor...Blood Cancer United
NCT07754604
Effects of Mental Fatigue Duration on Cortical Activity and Jump PerformanceInonu UniversityCompletedNot Applicable
NCT07754604Completed
Not Applicable
Effects of Mental Fatigue Duration on Cortical Activity and Jump PerformanceInonu University
NCT07755462
A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibular Syndesmosis With or Without Fixation of the Posterior Fragments in Bimalleolar or Equivalent FracturesGroupe Hospitalier Diaconesses Croix Saint-SimonActive Not RecruitingNot Applicable
NCT07755462Active Not Recruiting
Not Applicable
A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibula...Groupe Hospitalier Diacon...
NCT07754916
Comparison of Liposomal Bupivacaine Paravertebral Nerve Block Versus Intercostal Nerve Block on Postoperative Glycemic Variability in Patients Undergoing Minimally Invasive Pulmonary Resection: A Randomized Controlled Non-Inferiority TrialXiangya Hospital of Central South UniversityNot Yet RecruitingNot Applicable
NCT07754916Not Yet Recruiting
Not Applicable
Comparison of Liposomal Bupivacaine Paravertebral Nerve Block Versus Intercostal...Xiangya Hospital of Centr...
NCT07754175
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a TrialKang Stem Biotech Co., Ltd.Recruiting
NCT07754175Recruiting
—
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and...Kang Stem Biotech Co., Lt...
NCT07756593
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate CancerDendreonNot Yet RecruitingPhase 1
NCT07756593Not Yet Recruiting
Phase 1
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Mo...Dendreon
NCT07755774
Psychological Treatment for Adolescents With Self-injury Within Intensive Mental Health Outpatient Services: Randomized Controlled Pilot TrialKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07755774Not Yet Recruiting
Not Applicable
Psychological Treatment for Adolescents With Self-injury Within Intensive Mental...Karolinska Institutet
NCT07754162
Inter-Rater Reliability of Ultra Sound Based Rectus Abdominis Thickness Following Blood Flow Restriction TrainingRiphah International UniversityRecruiting
NCT07754162Recruiting
—
Inter-Rater Reliability of Ultra Sound Based Rectus Abdominis Thickness Followin...Riphah International Univ...
NCT07754292
Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeMedical College of WisconsinNot Yet RecruitingPhase 2
NCT07754292Not Yet Recruiting
Phase 2
Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeMedical College of Wiscon...
NCT07755384
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Tract at High Altitude (Zaduo County)Jilin UniversityRecruiting
NCT07755384Recruiting
—
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Trac...Jilin University
NCT07755124
Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Treatment of Rectal Cancer: A Randomized Controlled TrialWest China HospitalNot Yet RecruitingPhase 1
NCT07755124Not Yet Recruiting
Phase 1
Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Tre...West China Hospital
NCT07753928
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbHEnrolling By Invitation
NCT07753928Enrolling By Invitation
—
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbH
NCT07756177Active Not Recruiting
—
Guangzhou Preterm and Term Birth Cohort StudySun Yat-sen University
NCT07754578
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use PharmacotherapyMedical University of South CarolinaNot Yet RecruitingPhase 2
NCT07754578Not Yet Recruiting
Phase 2
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use PharmacotherapyMedical University of Sou...
NCT07755800
Impact of an Arginine-containing Toothpaste on the Subgingival Microbiota in Patients in Supportive Periodontal CareSukirth M Ganesan, BDS, PhDNot Yet RecruitingNot Applicable
NCT07755800Not Yet Recruiting
Not Applicable
Impact of an Arginine-containing Toothpaste on the Subgingival Microbiota in Pat...Sukirth M Ganesan, BDS, P...
NCT07755033
Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Multidimensional Health MarkersChinese Medical AssociationNot Yet RecruitingNot Applicable
NCT07755033Not Yet Recruiting
Not Applicable
Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Mult...Chinese Medical Associati...
NCT07755566
Effect of Papilozumib Oral on Vaginal and Intestinal Microbiota in HPV-Positive WomenEurofinsCompletedNot Applicable
NCT07755566Completed
Not Applicable
Effect of Papilozumib Oral on Vaginal and Intestinal Microbiota in HPV-Positive...Eurofins
NCT07755020
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial HospitalRecruiting
NCT07755020Recruiting
—
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial Hosp...
Result Breakdown
Not yet recruiting9 (45%)
Recruiting6 (30%)
Completed2 (10%)
Active, not recruiting2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified7 (35%)
Phase 12 (10%)
Phase 22 (10%)